Derafa Wassila, Aggoun Djouhra, Messasma Zakia, Houchi Selma, Bouacida Sofiane, Ourari Ali
Laboratory of Electrochemistry, Molecular Engineering and Redox Catalysis, Department of Process Engineering, Faculty of technology, University of Ferhat Abbas, Setif 19000, Algeria.
Chemistry Department, College of Science, Jouf University, Sakaka 72388, Saudi Arabia.
J Mol Struct. 2022 Sep 15;1264:133190. doi: 10.1016/j.molstruc.2022.133190. Epub 2022 Apr 30.
This work explores the study of a synthesized nickel complex as a possible inhibitor against the main protease (Mpro) of the recent emerging coronavirus disease (COVID-19). Overall, the template reaction of 3-acetyl-2-hydroxy-6-methyl-4-pyran-4-one with nickel(II) chloride hexahydrate in -dimethylformamide (DMF) medium leads to the formation of neutral nickel complex. This resulting complex is formulated as [Ni(DHA)(DMF)] on the basis of FT-IR, UV-Vis., single-crystal X-ray diffraction analysis, magnetic susceptibility and CV measurements as well as DFT quantum chemical calculations. Its single crystal suggests was found to be surrounded by the both pairs of molecules of DHA and DMF through six oxygen atoms with octahedral coordination sphere. The obtained magnetic susceptibilities are positive and agree with its paramagnetic state. In addition to the experimental investigations, optimized geometry, spectroscopic and electronic properties were also performed using DFT calculation with B3LYP/6-31G(d,p) level of theory. The nonlinear optical (NLO) properties of this complex are again examined. Some suitable quantum descriptors (E, E, Energy gap, Global hardness), Milliken atomic charge, Electrophilic potion and Molecular Electrostatic Potential) have been elegantly described. Molecular docking results demonstrated that the docked nickel complex displayed remarkable binding energy with Mpro. Besides, important molecular properties and ADME pharmacokinetic profiles of possible Mpro inhibitors were assessed by in silico prediction.
这项工作探索了一种合成镍配合物作为针对近期出现的冠状病毒病(COVID-19)主要蛋白酶(Mpro)的潜在抑制剂的研究。总体而言,3-乙酰基-2-羟基-6-甲基-4-吡喃-4-酮与六水合氯化镍(II)在二甲基甲酰胺(DMF)介质中的模板反应导致形成中性镍配合物。基于傅里叶变换红外光谱(FT-IR)、紫外可见光谱(UV-Vis.)、单晶X射线衍射分析、磁化率和循环伏安测量以及密度泛函理论(DFT)量子化学计算,该所得配合物被确定为[Ni(DHA)(DMF)]。其单晶显示,DHA和DMF的分子对通过六个氧原子围绕着镍原子,形成八面体配位球。所获得的磁化率为正值,与其顺磁状态相符。除了实验研究之外,还使用B3LYP/6-31G(d,p)理论水平的DFT计算对优化的几何结构、光谱和电子性质进行了研究。再次考察了该配合物的非线性光学(NLO)性质。还巧妙地描述了一些合适的量子描述符(E、E、能隙、全局硬度)、密立根原子电荷、亲电位点和分子静电势。分子对接结果表明,对接的镍配合物与Mpro显示出显著的结合能。此外,通过计算机预测评估了可能的Mpro抑制剂的重要分子性质和药物代谢动力学(ADME)特征。